Shimshak T M, Preuss K C, Gross G J, Brooks H L, Warltier D C
Cardiovasc Res. 1986 Aug;20(8):621-6. doi: 10.1093/cvr/20.8.621.
The effects of intravenous administration of nicorandil, a new antianginal agent, on the recovery of regional myocardial contractile function after a 10 minute coronary artery occlusion were studied in chronically instrumented conscious dogs. Compared with the control group nicorandil administration resulted in an increase in heart rate and a decrease in blood pressure with an overall increase in the double product during the preocclusion period, no significant difference in double product during ischaemia, and a significant decrease in double product during reperfusion. After reperfusion the return of regional contractile function was appreciably enhanced in the nicorandil treated group. These effects were seen immediately after coronary reflow and persisted throughout the reperfusion period. These data suggest that nicorandil protects ischaemic cardiac tissue, and that the beneficial actions may be mediated through a reduction in left ventricular afterload.
在长期植入仪器的清醒犬中,研究了新型抗心绞痛药物尼可地尔静脉给药对冠状动脉闭塞10分钟后局部心肌收缩功能恢复的影响。与对照组相比,给药前尼可地尔使心率增加、血压降低,双乘积总体增加;缺血期间双乘积无显著差异;再灌注期间双乘积显著降低。再灌注后,尼可地尔治疗组局部收缩功能的恢复明显增强。这些作用在冠状动脉再灌注后立即出现,并在整个再灌注期持续存在。这些数据表明,尼可地尔可保护缺血心肌组织,其有益作用可能是通过降低左心室后负荷介导的。